{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:47:17Z","timestamp":1767134837531,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd009369","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T00:00:00Z","timestamp":1412640000000}}],"reference-count":68,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009369.pub2","type":"journal-article","created":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T14:40:14Z","timestamp":1412692814000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia"],"prefix":"10.1002","volume":"2014","author":[{"given":"Magdolna","family":"Tardy","sequence":"first","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen Klinikum rechts der Isar; Klinik und Poliklinik f\u00fcr Psychiatrie und Psychotherapie; M\u00f6hlstr. 26 M\u00fcnchen Germany 81675"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Huhn","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinikum der Technischen Universit\u00e4t M\u00fcnchen; Klinik und Poliklinik f\u00fcr Psychiatrie und Psychotherapie; Klinikum rechts der Isar M\u00fcnchen Bavaria Germany 81675"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf R","family":"Engel","sequence":"additional","affiliation":[{"name":"Ludwig-Maximilians-University Munich; Psychiatric Hospital; Nussbaumstr. 7 Muenchen Germany 80336"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen; Department of Psychiatry and Psychotherapy; Ismaningerstrasse 22 M\u00fcnchen Germany 81675"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,10,7]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD009369.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00005053-196206000-00008","article-title":"A study of phenothiazines with males and female chronically ill schizophrenic patients","volume":"134","author":"Adelson","year":"1962","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00403632","article-title":"The comparative effectiveness of eight phenothiazines","volume":"7","author":"Hanlon","year":"1965","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005053-196107000-00001","article-title":"The comparative effectiveness of six phenothiazine compounds, phenobarbital and inert placebo in the treatment of acutely ill patients: global measures of severity of illness","volume":"133","author":"Kurland","year":"1961","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"2","key":"10.1002\/14651858.CD009369.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1600-0447.1993.tb03335.x","article-title":"Poor neuroleptic response in acutely exacerbated schizophrenic patients","volume":"87","author":"Shalev","year":"1993","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"1","key":"10.1002\/14651858.CD009369.pub2-BIB0005|cit5","first-page":"1","article-title":"Current status of pharmacotherapy in schizophrenia","volume":"20","author":"Akimoto","year":"1966","journal-title":"Folia Psychiatrica et Neurologica Japonica"},{"issue":"7","key":"10.1002\/14651858.CD009369.pub2-BIB0006|cit6","first-page":"7","article-title":"A new comparison of antipsychotic drugs","volume":"22","author":"Anon","year":"2006","journal-title":"Harvard Mental Health Letter"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/archpsyc.1961.01710100093011","article-title":"Five phenothiazine derivatives. Evaluation and toxicity studies","volume":"4","author":"Bennett","year":"1961","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1176\/ajp.117.2.97","article-title":"Treatment of schizophrenic reactions with phenothiazine derivatives","volume":"August 1960","author":"Casey","year":"1960","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD009369.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archpsyc.1974.01760070072011","article-title":"Specific indications for different classes of phenothiazines","volume":"30","author":"Hollister","year":"1974","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD009369.pub2-BIB0010|cit10","first-page":"403","article-title":"A double-blind evaluation of chlorpromazine versus a combination of perphenazine and amitriptyline","volume":"3","author":"Lapolla","year":"1967","journal-title":"International Journal of Neuropsychiatry"},{"issue":"3","key":"10.1002\/14651858.CD009369.pub2-BIB0011|cit11","first-page":"285","article-title":"Atypical versus typical antipsychotic treatment prognosis in first-episode paranoid schizophrenia based on wcst and dichotic listening scores","volume":"11","author":"Loza","year":"2001","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0012|cit12","first-page":"227","article-title":"Tardive dyskinesia: pathophysiological mechanisms and clinical trials","volume":"14","author":"Gerlach","year":"1988","journal-title":"L'Encephale"},{"issue":"4","key":"10.1002\/14651858.CD009369.pub2-BIB0013|cit13","first-page":"423","article-title":"Effect of different neuroleptics in tardive dyskinesia and parkinsonism. A video-controlled multicenter study with chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden","volume":"90","author":"Nordic Dyskinesia Study Group","year":"1986","journal-title":"Psychopharmacology"},{"issue":"25","key":"10.1002\/14651858.CD009369.pub2-BIB0014|cit14","first-page":"1682","article-title":"The effects of neuroleptics on tardive dyskinesias. A video-controlled, randomized study of chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden","volume":"149","author":"Povlsen","year":"1987","journal-title":"Ugeskrift for Laeger"},{"issue":"12","key":"10.1002\/14651858.CD009369.pub2-BIB0015|cit15","first-page":"366","article-title":"Trilafon (perphenazine) and largactil (chlorpromazine) in chronic schizophrenia. A comparison","volume":"120","author":"Schulsinger","year":"1958","journal-title":"Ugeskrift For Laeger"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1176\/ajp.116.5.392","article-title":"A graphic comparison of five phenothiazines","volume":"116","author":"Smith","year":"1959","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD009369.pub2-BIB0017|cit17","first-page":"93","article-title":"A comparison of pimozide with perphenazine in the treatment of acute schizophrenic psychoses","volume":"14","author":"Svestka","year":"1972","journal-title":"Activitas Nervosa Superior"},{"issue":"3","key":"10.1002\/14651858.CD009369.pub2-BIB0018|cit18","first-page":"165","article-title":"A controlled comparison of oxypertine and perphenazine in schizophrenic psychoses","volume":"16","author":"Svestka","year":"1974","journal-title":"Activitas Nervosa Superior"},{"issue":"2","key":"10.1002\/14651858.CD009369.pub2-BIB0019|cit19","first-page":"315","article-title":"Differences in therapeutic effects of phenothiazine drugs","volume":"9","author":"Vinar","year":"1968","journal-title":"Agressologie"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.biopsych.2009.08.040","article-title":"Antipsychotic drug equivalents and dose-years: a standardized method for comparing exposure to different drugs","volume":"67","author":"Andreasen","year":"2010","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0022|cit22","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM III)","author":"American Psychiatric Association","year":"1980"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0023|cit23","volume-title":"Psychische Erkrankungen. Klinik und Therapie","author":"Berger","year":"2003"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD009369.pub2-BIB0025|cit25","first-page":"405","article-title":"The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/135581960000500105","article-title":"Sample size calculations for cluster randomised trials. Changing Professional Practice in Europe Group (EU BIOMED II Concerted Action)","volume":"5","author":"Campbell","year":"2000","journal-title":"Journal of Health Services Research and Policy"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM199403103301006","article-title":"Schizophrenia","volume":"330","author":"Carpenter","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD009369.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1176\/ajp.132.12.1237","article-title":"Overview: maintenance therapy in psychiatry: I. Schizophrenia","volume":"132","author":"Davis","year":"1975","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0029|cit29","article-title":"Antipsychotic drugs","volume-title":"Comprehensive Textbook of Psychiatry","author":"Davis","year":"1989"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0030|cit30","unstructured":"Deeks J Issues in the selection for meta-analyses of binary data Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25-28th; Cape Town, South Africa Cape Town 2000"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"Der-Simonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD009369.pub2-BIB0033|cit33","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009831","article-title":"Haloperidol versus first generation antipsychotics for schizophrenia","author":"Dold","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"13","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/15622970510030090","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) - guidelines for biological treatment of schizophrenia, part 1: Acute treatment of schizophrenia","volume":"6","author":"Falkai","year":"2005","journal-title":"World Journal of Biological Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD009369.pub2-BIB0037|cit37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001944.pub2","article-title":"Thioridazine for schizophrenia","author":"Fenton","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD009369.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0039|cit39","volume-title":"Behandlungsleitlinie Schizophrenie","author":"Gaebel","year":"2006"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0040|cit40","unstructured":"GRADE Working Group GRADE Profiler 2004"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0042|cit42","volume-title":"Dosierung der Neuroleptika. Ein Leitfaden f\u00fcr Klinik und Praxis unter besonderer Ber\u00fccksichtigung psychotisch Kranker","author":"Haase","year":"1983"},{"issue":"1","key":"10.1002\/14651858.CD009369.pub2-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009369","article-title":"Perphenazine for schizophrenia","author":"Hartung","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0044|cit44","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org 2011"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.63.10.1079","article-title":"Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia - cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1)","volume":"63","author":"Jones","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0046|cit46","volume-title":"Positive and Negative Syndrome Scale (PANSS) Manual","author":"Kay","year":"1986"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0047|cit47","volume-title":"Diagnosis and Drug Treatment of Psychiatric Disorders","author":"Klein","year":"1969"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0048|cit48","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia, second edition","volume":"161","author":"Lehman","year":"2004","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.biopsych.2005.10.020","article-title":"Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology","volume":"59","author":"Leon","year":"2006","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.187.4.366","article-title":"Clinical implications of Brief Psychiatric Rating Scale Scores","volume":"187","author":"Leucht","year":"2005","journal-title":"British Journal of Psychiatry"},{"issue":"9657","key":"10.1002\/14651858.CD009369.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0054|cit54","first-page":"820","article-title":"Psychopharmaka","volume-title":"Arzneimittelverordnungsreport","author":"Lohse","year":"2005"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00127-004-0762-4","article-title":"Schizophrenia and employment - a review","volume":"39","author":"Marwaha","year":"2004","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0059|cit59","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/9780470712184.ch12","article-title":"Chapter 12: Interpreting results and drawing conclusions","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Sch\u00fcnemann","year":"2008"},{"issue":"4194","key":"10.1002\/14651858.CD009369.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.1145194","article-title":"Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons","volume":"188","author":"Seeman","year":"1975","journal-title":"Science"},{"issue":"9","key":"10.1002\/14651858.CD009369.pub2-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009227","article-title":"Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia","author":"Tardy","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD009369.pub2-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009230","article-title":"Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia","author":"Tardy","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD009369.pub2-BIB0064|cit64","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009268","article-title":"Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia","author":"Tardy","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD009369.pub2-BIB0065|cit65","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009396","article-title":"Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia","author":"Tardy","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD009369.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jclinepi.2004.02.018","article-title":"Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time","volume":"57","author":"Trikalinos","year":"2004","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD009369.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/archpsyc.1978.01770260031002","article-title":"Suicide in schizophrenics, manics, depressives, and surgical controls: a comparison with general population suicide mortality","volume":"35","author":"Tsuang","year":"1978","journal-title":"Archives of General Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD009369.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1192\/pb.bp.108.021949","article-title":"Loss to outcomes stakeholder survey: the LOSS study","volume":"33","author":"Xia","year":"2009","journal-title":"Psychiatric Bulletin"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD009369.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T06:42:15Z","timestamp":1714200135000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009369.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,7]]},"references-count":68,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009369.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,7]]}}}